Christiane Margue

Belvaux, ES L4367, Luxembourg

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

High-throughput drug screening in advanced pre-clinical 3D melanoma models identifies potential first-line therapies for NRAS-mutated melanoma.

High-throughput drug screening in advanced pre-clinical 3D melanoma models identifies potential first-line therapies for NRAS-mutated melanoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 27, 2025

Protocol to generate scaffold-free, multicomponent 3D melanoma spheroid models for preclinical drug testing.

Protocol to generate scaffold-free, multicomponent 3D melanoma spheroid models for preclinical drug testing.

Journal: STAR protocols

Published: February 01, 2024

A multi-omics integrative approach unravels novel genes and pathways associated with senescence escape after targeted therapy in NRAS mutant melanoma.

A multi-omics integrative approach unravels novel genes and pathways associated with senescence escape after targeted therapy in NRAS mutant melanoma.

Journal: Cancer gene therapy

Published: March 24, 2023

Inhibition of extracellular vesicle-derived miR-146a-5p decreases progression of melanoma brain metastasis via Notch pathway dysregulation in astrocytes.

Inhibition of extracellular vesicle-derived miR-146a-5p decreases progression of melanoma brain metastasis via Notch pathway dysregulation in astrocytes.

Journal: Journal of extracellular vesicles

Published: March 16, 2023

Single-cell transcriptomics of NRAS-mutated melanoma transitioning to drug resistance reveals P2RX7 as an indicator of early drug response.

Single-cell transcriptomics of NRAS-mutated melanoma transitioning to drug resistance reveals P2RX7 as an indicator of early drug response.

Journal: Cell reports

Published: November 30, 2022

Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma.

Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma.

Journal: Cell death & disease

Published: October 03, 2022

Cross-Linking Ligation and Sequencing of Hybrids (qCLASH) Reveals an Unpredicted miRNA Targetome in Melanoma Cells.

Cross-Linking Ligation and Sequencing of Hybrids (qCLASH) Reveals an Unpredicted miRNA Targetome in Melanoma Cells.

Journal: Cancers

Published: January 26, 2021

NRAS mutant melanoma: Towards better therapies.

NRAS mutant melanoma: Towards better therapies.

Journal: Cancer treatment reviews

Published: January 26, 2021

Systematic Transcriptional Profiling of Responses to STAT1- and STAT3-Activating Cytokines in Different Cancer Types.

Systematic Transcriptional Profiling of Responses to STAT1- and STAT3-Activating Cytokines in Different Cancer Types.

Journal: Journal of molecular biology

Published: July 20, 2020

Distinct Cargos of Small Extracellular Vesicles Derived from Hypoxic Cells and Their Effect on Cancer Cells.

Distinct Cargos of Small Extracellular Vesicles Derived from Hypoxic Cells and Their Effect on Cancer Cells.

Journal: International journal of molecular sciences

Published: June 17, 2020

Hypoxia-Induced Adaptations of miRNomes and Proteomes in Melanoma Cells and Their Secreted Extracellular Vesicles.

Hypoxia-Induced Adaptations of miRNomes and Proteomes in Melanoma Cells and Their Secreted Extracellular Vesicles.

Journal: Cancers

Published: February 27, 2020

Many ways to resistance: How melanoma cells evade targeted therapies.

Many ways to resistance: How melanoma cells evade targeted therapies.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: December 04, 2018

Showing 1-12 of 22

Last Updated: 09/26/2026